article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

No surrogate marker (selecting a development candidate, starting human trials, or (arguably) even launching a drug are reliable indicators of the only things that matter: real-world clinical utility and commercial success.